5 employees
BioLeap offers a proprietary technology platform to identify and optimize lead compounds to discover novel drugs.
2002
$5M
from 1 investors over 1 rounds
Bioleap, Inc. raised $5M on January 12, 2010
Investors: ACM Remodeling